Bioanalytical services specialist Alderley Analytical has been acquired by Dutch firm Synexa Life Sciences. Synexa is backed by major European healthcare investor Gilde Healthcare. Alderley Analytical, founded in 2013 and operational since 2014, has grown significantly since securing initial investment from River Capital and has established itself as a key player in supporting drug development … Continue reading River Capital exits Alderley Analytical to European firm